© 2021 NESTED BIO. All rights reserved.
Menu
Nested Bio is a venture development company focusing in Medical Devices, Diagnostics, Pharmaceuticals and Cleantech. We create ideas, accelerate development and mature new businesses. Within Nested Bio we are creating entirely new concepts challenging convention and commercial assumptions. With a backing of strong investor network in Europe, we can help you and your company grow quicker with a solid foundation.
Strategic investments with focus on corporate and tech growth and maturation.
On Demand Product Innovation, Product Development and Life Cycle Management of Medical Devices, Diagnostics, Pharmaceuticals & Cleantech Innovations.
Third Party Evaluation and Validation of your Technology (or Concepts!), giving you technical insights and risk assessments.
From IP Protection to mediating commercialisation and tech transfer of your IP.
Managing Director
CEO, Prolevi Bio AB
Principal Scientist
at Spermosens AB
Activities
Initial Public Offering
Investments & Corporate Affiliates
Strategic Investments
Currently Supporting
(exceeding)
The novel diagnostic device will help the patients and healthcare provider to probe the underlying cause of unexplained male infertility, and to select the most suitable infertility treatment.
Nested Bio has provided Management Resources & Subject Matter Expertise (Intellectual Property, Life Science Expertise, Product Strategy) to Spermosens. Punyani is the Founding Partner and consults in the current Management of Spermosens as well as serves on the BoD.
SPERM; Spotlight Stock Market, Stockholm
Spermosens is commercialising a revolutionary platform technology and what will be the first functional male infertility diagnostic device to directly predict the fusion capacity of sperms.
The company was founded during the COVID-19 pandemic in 2020 with the express goal to revolutionise diagnosis of infectious diseases.
Nested Bio has served as a Tech Advisor for Diagonal Bio, since Punyani founded Diagonal Bio. Punyani also serves on the Board of Diagonal Bio.
DIABIO; Nasdaq First North Growth Market, Stockholm
Nested Bio has served as a Tech Advisor for Diagonal Bio until 2021, since Punyani founded Diagonal Bio. Punyani also served on the Board of Diagonal Bio.
Prolevi Bio is developing and clinically testing an advanced drug formulation platform for metabolic and hormonal disorders. The company was founded in Dec 2021.
Nested Bio is an early stage investor and Punyani serves on the Board.
Punyani co-founded Avsalt, while assisting in securing the seed financing and intellectual property of the invention. Punyani exit the company in 2020.
Avsalt is a Swedish cleantech company with R&D extending to TU Delft, Netherlands, developing a novel desalination system invented by Dr Niels Boon.
Punyani co-founded Thyrolytics, and briefly served as its CTO. Besides contributing to the product development and IP portfolio, Punyani maintained stakeholder relationships and identified the route of enzyme production in collaboration with Karolinska Institute. Punyani exited the company in 2020.
Acquired by Aegirbio AB (AEGIR; Nasdaq First North Growth Market, Stockholm)
Thyrolytics is developing a patented enzymatic thyroid hormone In Vitro Diagnostic using recombinant Iodothyronine Deiodinases.
Awards, markets, acquisitions and foundations.
If you are looking for financing and management advice for your startup, or just have a cool idea, feel free to contact!
MEDICON VILLAGE
Scheeletorget 1
223 81 Lund, Sweden
© 2021 NESTED BIO. All rights reserved.